215 related articles for article (PubMed ID: 1668145)
1. Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling?
Kermekchiev M; Pettersson M; Matthias P; Schaffner W
Gene Expr; 1991 Apr; 1(1):71-81. PubMed ID: 1668145
[TBL] [Abstract][Full Text] [Related]
2. Synergism between immunoglobulin enhancers and promoters.
Garcia JV; Bich-Thuy LT; Stafford J; Queen C
Nature; 1986 Jul 24-30; 322(6077):383-5. PubMed ID: 3016550
[TBL] [Abstract][Full Text] [Related]
3. Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.
Phares W; Herr W
J Virol; 1991 May; 65(5):2200-10. PubMed ID: 1850006
[TBL] [Abstract][Full Text] [Related]
4. Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions.
Fulton R; Van Ness B
Nucleic Acids Res; 1993 Oct; 21(21):4941-7. PubMed ID: 8177743
[TBL] [Abstract][Full Text] [Related]
5. An immunoglobulin promoter displays cell-type specificity independently of the enhancer.
Foster J; Stafford J; Queen C
Nature; 1985 May 30-Jun 5; 315(6018):423-5. PubMed ID: 3923370
[TBL] [Abstract][Full Text] [Related]
6. Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers.
Fulton R; van Ness B
Nucleic Acids Res; 1994 Oct; 22(20):4216-23. PubMed ID: 7937148
[TBL] [Abstract][Full Text] [Related]
7. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
Elmaleh N; Matthias P; Schaffner W
Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
[TBL] [Abstract][Full Text] [Related]
8. Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.
Kawakami K; Scheidereit C; Roeder RG
Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4700-4. PubMed ID: 3133660
[TBL] [Abstract][Full Text] [Related]
9. Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer.
Currie RA; Roeder RG
Mol Cell Biol; 1989 Oct; 9(10):4239-47. PubMed ID: 2511430
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mouse and rabbit Ei kappa enhancers indicates that different elements within the enhancer may mediate activation of transcription and recombination.
Coquilleau I; Cavelier P; Rougeon F; Goodhardt M
J Immunol; 2000 Jan; 164(2):795-804. PubMed ID: 10623825
[TBL] [Abstract][Full Text] [Related]
11. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
12. Long-range activation of transcription by SV40 enhancer is affected by "inhibitory" or "permissive" DNA sequences between enhancer and promoter.
Schreiber E; Schaffner W
Somat Cell Mol Genet; 1989 Nov; 15(6):591-603. PubMed ID: 2556801
[TBL] [Abstract][Full Text] [Related]
13. The importance of the 3'-enhancer region in immunoglobulin kappa gene expression.
Meyer KB; Sharpe MJ; Surani MA; Neuberger MS
Nucleic Acids Res; 1990 Oct; 18(19):5609-15. PubMed ID: 2120679
[TBL] [Abstract][Full Text] [Related]
14. Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells.
Chen HM; Boxer LM
Mol Cell Biol; 1995 Jul; 15(7):3840-7. PubMed ID: 7791791
[TBL] [Abstract][Full Text] [Related]
15. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
Park K; Atchison ML
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
[TBL] [Abstract][Full Text] [Related]
16. Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.
Liu Z; Garrard WT
Mol Cell Biol; 2005 Apr; 25(8):3220-31. PubMed ID: 15798207
[TBL] [Abstract][Full Text] [Related]
17. Identification of an octamer-binding site in the human kappa light-chain enhancer.
Nelms K; Van Ness B
Mol Cell Biol; 1990 Jul; 10(7):3843-6. PubMed ID: 2113179
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the promoter for human immunoglobulin gamma3 germ-line transcription and its interaction with the 3'alpha enhancer.
Pan Q; Petit-Frére C; Stavnezer J; Hammarström L
Eur J Immunol; 2000 Apr; 30(4):1019-29. PubMed ID: 10760789
[TBL] [Abstract][Full Text] [Related]
19. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site.
Pelletier MR; Hatada EN; Scholz G; Scheidereit C
Nucleic Acids Res; 1997 Oct; 25(20):3995-4003. PubMed ID: 9321649
[TBL] [Abstract][Full Text] [Related]
20. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
Lin MM; Green NS; Zhang W; Scharff MD
Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
